CHTH · As filed with the SEC

CNL Healthcare Properties income statement, by quarter

The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) · USD thousands, except per-share amounts; shares in thousands

USD thousands, except per-share amounts; shares in thousands	Q3 2025 3 months ended Sep 30, 2025	Q2 2025 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	Q2 2024^† 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024	Q4 2023^† 3 months ended Dec 31, 2023
Revenues:
Rental income and related revenues	—	—	—	—	6,920	6,819	6,800	6,754^†
Rental income and related revenues	7,551	7,002	6,834	6,759^†	6,920^†	6,819^†	—	—
Resident fees and services	91,743	90,362	88,805	86,439^†	85,877	84,065	82,281	79,668^†
Total revenues	99,294	97,364	95,639	93,198^†	92,797	90,884	89,081	86,422^†
Operating expenses:
Property operating expenses	66,439	64,488	64,259	63,765^†	62,582	58,558	60,632	59,837^†
General and administrative expenses	2,537	2,181	2,336	2,508^†	1,841	2,194	2,216	2,532^†
Asset management fees	3,452	3,452	3,489	3,342^†	3,337	3,337	3,337	3,429^†
Property management fees	4,537	4,496	4,377	4,283^†	4,277	4,112	4,040	3,895^†
Financing coordination fees	—	—	—	0^†	0	0	—	2,508^†
Depreciation and amortization	12,901	13,197	12,712	12,904^†	12,619	12,641	12,525	12,493^†
Total operating expenses	89,866	87,814	87,173	86,802^†	84,656	80,842	82,750	84,694^†
Gain on sale of real estate	—	—	—	—	—	—	—	0^†
Operating income	9,428	9,550	8,466	6,396^†	8,141	10,042	6,331	1,728^†
Other income (expense):
Interest and other income	113	150	113	196^†	356	230	359	603^†
Interest expense and loan cost amortization	(10,938)	(11,038)	(10,985)	(11,294)^†	(11,527)	(11,442)	(11,595)	(11,193)^†
Total other expense	(10,825)	(10,888)	(10,872)	(11,098)^†	(11,171)	(11,212)	(11,236)	(10,590)^†
Loss before income taxes	(1,397)	(1,338)	(2,406)	(4,702)^†	(3,030)	(1,170)	(4,905)	(8,862)^†
Income tax expense	(181)	(154)	(162)	(248)^†	(125)	(123)	(115)	(239)^†
Net loss	(1,578)	(1,492)	(2,568)	(4,950)^†	(3,155)	(1,293)	(5,020)	(9,101)^†
Less: Amounts attributable to noncontrolling interests	0	0	0	1^†	19	9	15	17^†
Net loss attributable to common stockholders	(1,578)	(1,492)	(2,568)	(4,951)^†	(3,174)	(1,302)	(5,035)	(9,118)^†
Net loss per share of common stock, basic (in dollars per share)	(0.01)	(0.01)	(0.01)	—	(0.02)	(0.01)	(0.03)	—
Net loss per share of common stock, diluted (in dollars per share)	(0.01)	(0.01)	(0.01)	—	(0.02)	(0.01)	(0.03)	—
Weighted average number of shares of common stock outstanding, basic (in shares)	173,942	173,942	173,942	—	173,942	173,942	173,942	—
Weighted average number of shares of common stock outstanding, diluted (in shares)	173,942	173,942	173,942	—	173,942	173,942	173,942	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.